🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2031

Annual patent cliff calendar for 2031 — US pharmaceutical patents by expiration date.

Patents
874

Quick answer

874 indexed pharmaceutical patents have expiration dates in 2031. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7867983

    Methods to protect skeletal muscle against injury

    The United States of America as represented by the Secretary of the Army · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7867476

    Method and materials for use in diagnosing viral myocarditis

    The Regents of the University of California · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7868006

    Heterocyclic substituted piperazines with CXCR3 antagonist activity

    Pharmacopeia Drug Discovery, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7868169

    Crystalline rosuvastatin intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7867500

    Cofactor that modulates steroid receptor activities

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7867275

    Coated implantable medical device method

    Cook Regentec LLC · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7868160

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7868162

    Antimicrobial and antiviral compounds and methods for their use

    Lakewood Amedex, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7868013

    Cycloalkyl substituted pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7867977

    Immunogenic peptides and methods of use for treating and preventing cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7867171

    Management of gastro-intestinal disorders

    EXALENZ BIOSCIENCE LTD. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7867515

    Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof

    Teva Womans's Health, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7868176

    Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation

    ACADIA Pharmaceuticals Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7867512

    Cross-linked polymersomes and related encapsulating membranes

    Regents of the University of Minnesota · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7868175

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7871986

    Methods of stimulating an immune response against prostate specific antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7871814

    Recombinant bicistronic flaviviruses and methods of use thereof

    The Regents of the University of California · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7872096

    Methods for cyclizing synthetic polymers

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7872082

    Method for preparing polymer maleimides

    Nektar Therapeutics · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7871775

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7872031

    c-MET protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7872110

    Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection

    United Biomedical, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7872000

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7871620

    Immunoliposomes that optimize internationalization into target cells

    The Regents of the University of California · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7872124

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7871607

    Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases

    HALOZYME, INC. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7872072

    Branched polymers and their conjugates

    Nektar Therapeutics · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7872129

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7871993

    Tigecycline crystalline forms and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7871778

    Methods of diagnosing endometriosis

    The Regents of the University of California · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7871981

    Inhibition of cell motility, angiogenesis, and metastasis

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7871985

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7871997

    Cephalosporin compounds

    Theravance, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7875632

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7875637

    Benzimidazole derivative and use as a II receptor antagonist

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7875598

    Compositions useful for the treatment of microbial infections

    The Regents of the University of California · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7875276

    Urinary tract tissue graft compositions and methods for producing same

    The Board of Regents of the University of Oklahoma · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7875711

    Compositions and methods for inhibiting expression of XBP-1 gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7875292

    Orally disintegrable tablets

    Takeda Pharmaceutical Company Limited · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7875450

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7875284

    Methods of manufacturing and modifying taxane coatings for implantable medical devices

    Cook Regentec LLC · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7875622

    Methods and compositions for treating pulmonary hypertension and related diseases and disorders

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7875712

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7875628

    Cyclopamine analogues and methods of use thereof

    Infinity Discovery, Inc. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7875629

    Quinolinone compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Tue Jan 25 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7879891

    Caspase inhibitor prodrugs

    Vertex Pharmaceuticals Incorporated · Granted Tue Feb 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2031?

874 published patents in our USPTO index have expiration dates falling in calendar year 2031.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.